Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $268.46 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $113.87 | 1 | $0 (2017) |
| Lilly USA, LLC | $81.10 | 1 | $0 (2023) |
| Vifor Pharma, Inc. | $33.08 | 2 | $0 (2021) |
| Gilead Sciences Inc | $24.89 | 1 | $0 (2017) |
| Calliditas Therapeutics US Inc. | $15.52 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $96.62 | 2 | Lilly USA, LLC ($81.10) |
| 2021 | $33.08 | 2 | Vifor Pharma, Inc. ($33.08) |
| 2017 | $138.76 | 2 | Otsuka America Pharmaceutical, Inc. ($113.87) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Nephrology | ||||||
| 05/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $81.10 | General |
| Category: Diabetes | ||||||
| 08/23/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Hyperkalemia | ||||||
| 07/07/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Hyperkalemia | ||||||
| 12/05/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $113.87 | General |
| Category: NEPHROLOGY | ||||||
| 05/30/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $24.89 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 307 | 386 | $113,576 | $37,913 |
| 2022 | 8 | 323 | 393 | $113,358 | $38,445 |
| 2021 | 6 | 240 | 302 | $86,744 | $28,188 |
| 2020 | 5 | 224 | 273 | $70,910 | $18,846 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 169 | $61,516 | $17,967 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 124 | $30,628 | $8,725 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $5,845 | $5,478 | 93.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 27 | $13,203 | $4,018 | 30.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 15 | 15 | $1,344 | $1,132 | 84.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $1,040 | $594.24 | 57.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 157 | $55,421 | $16,735 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 100 | $24,000 | $7,380 | 30.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 46 | $21,850 | $6,428 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $4,582 | $4,526 | 98.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 15 | 15 | $4,695 | $1,227 | 26.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 15 | 15 | $1,260 | $1,054 | 83.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $1,040 | $585.87 | 56.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $510.00 | $509.43 | 99.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 136 | $46,648 | $13,735 | 29.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 38 | $17,518 | $5,496 | 31.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 76 | $17,708 | $4,866 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 18 | 18 | $2,592 | $2,621 | 101.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 17 | 17 | $1,173 | $1,109 | 94.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 17 | $1,105 | $359.72 | 32.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 100 | $32,900 | $8,183 | 24.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 106 | 134 | $30,150 | $7,042 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 16 | 16 | $2,240 | $2,253 | 100.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 11 | $4,840 | $1,118 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 12 | 12 | $780.00 | $250.32 | 32.1% |
About Dr. Daniel Hwang, M.D
Dr. Daniel Hwang, M.D is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871683532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Hwang, M.D has received a total of $268.46 in payments from pharmaceutical and medical device companies, with $96.62 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($268.46).
As a Medicare-enrolled provider, Hwang has provided services to 1,094 Medicare beneficiaries, totaling 1,354 services with total Medicare billing of $123,393. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Daly City, CA
- Active Since 10/13/2006
- Last Updated 06/22/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871683532
Products in Payments
- SAMSCA (Drug) $113.87
- MOUNJARO (Drug) $81.10
- Veltassa (Drug) $33.08
- TARPEYO (Drug) $15.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Dr. Alice Yan, M.d, M.D
Internal Medicine — Payments: $22,968
Damon Lee, Md, MD
Internal Medicine — Payments: $20,608
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620